Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
World Neurosurgery|November 4, 2017
Effect of Progesterone on Cerebral Vasospasm and Neurobehavioral Outcomes in a Rodent Model of Subarachnoid HemorrhageNefize Turan, Brandon A Miller, J Russell Huie, et al.
Journal of Medicinal Chemistry|April 7, 2023
Neurotherapeutic Potential of Water-Soluble pH-Responsive Prodrugs of EIDD-036 in Traumatic Brain InjuryRussell G Fritzemeier, Aletta E van der Westhuyzen, Michael D'Erasmo, et al.
Experimental Biology and Medicine (Maywood, N.J.)|September 27, 2021
Osteopontin as a biomarker for COVID-19 severity and multisystem inflammatory syndrome in children: A pilot studyAndrew Reisner, Laura S Blackwell, Iqbal Sayeed, et al.
NPJ Vaccines|October 28, 2024
Divergence of variant antibodies following SARS-CoV-2 booster vaccines in myeloma and impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Research Square|October 4, 2023
Divergence of variant binding/neutralizing antibodies following SARS-CoV-2 booster vaccines in myeloma: Impact of hybrid immunityAlberto Moreno, Kelly Manning, Maryam I Azeem, et al.
Biorxiv : the Preprint Server for Biology|November 16, 2022
mRNA bivalent booster enhances neutralization against BA.2.75.2 and BQ.1.1Meredith E Davis-Gardner, Lilin Lai, Bushra Wali, et al.
Medrxiv : the Preprint Server for Health Sciences|December 9, 2022
Durability of immune responses to the booster mRNA vaccination against COVID-19Prabhu S Arunachalam, Lilin Lai, Hady Samaha, et al.
Plos Pathogens|December 2, 2025
Monocyte-eosinophil signaling axis promotes vaccine-mediated protection against SARS-CoV-2Kathryn M Moore, Stephanie L Foster, Meenakshi Kar, et al.
Biorxiv : the Preprint Server for Biology|August 30, 2024
Eosinophils protect against SARS-CoV-2 following a vaccine breakthrough infectionKathryn M Moore, Stephanie L Foster, Meenakshi Kar, et al.
Pageof 4